Financhill
Back

Alnylam Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:
$407.55
Seasonality Move:
2.83%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

Alnylam Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 398.62 Buy
20-day SMA: 425.76 Sell
50-day SMA: 445.45 Sell
200-day SMA: 366.47 Buy
8-day EMA: 404.19 Buy
20-day EMA: 419.22 Sell
50-day EMA: 433.64 Sell
200-day EMA: 382.97 Buy

Alnylam Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -14.68 Sell
Relative Strength Index (14 RSI): 41.22 Sell
Chaikin Money Flow: -134790 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (403.82 - 458.66) Sell
Bollinger Bands (100): (426.36 - 469.58) Sell

Alnylam Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Alnylam Pharmaceuticals, Inc. Stock

Is Alnylam Pharmaceuticals, Inc. Stock a Buy?

ALNY Technical Analysis vs Fundamental Analysis

Buy
51
Alnylam Pharmaceuticals, Inc. (ALNY) is a Buy

Is Alnylam Pharmaceuticals, Inc. a Buy or a Sell?

Alnylam Pharmaceuticals, Inc. Stock Info

Market Cap:
53.9B
Price in USD:
407.73
Share Volume:
1.1M

Alnylam Pharmaceuticals, Inc. 52-Week Range

52-Week High:
495.55
52-Week Low:
205.87
Buy
51
Alnylam Pharmaceuticals, Inc. (ALNY) is a Buy

Alnylam Pharmaceuticals, Inc. Share Price Forecast

Is Alnylam Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Alnylam Pharmaceuticals, Inc.

Is Alnylam Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.20 per share, and an increase next year of $6.23 per share.

Technical Analysis of Alnylam Pharmaceuticals, Inc.

Should I short Alnylam Pharmaceuticals, Inc. stock?

* Alnylam Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.